CHELSEA EASTMAN: Open Payments
NPI 1578964193 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 27 payments from 6 companies in 2025. Trend: 2023 $307 · 2024 $861 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $357 |
| LivaNova USA, Inc. | 9 | $150 |
| SK Life Science, Inc. | 4 | $120 |
| JAZZ PHARMACEUTICALS INC. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Neurelis, Inc. | 1 | $25 |
Products named: Fintepla, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Briviact, EPIDIOLEX, AUSTEDO XR, VALTOCO.
Industry payments across WA — which companies pay providers there.
